Release Date: 14/09/09 09:39 Summary: 2009 CWT Annual Report Price Sensitive: No Download Document 3.39MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%